Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $10.8 million.

  • Innoviva's Cash from Financing Activities rose 17729.93% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 million, marking a year-over-year increase of 9905.45%. This contributed to the annual value of -$13.5 million for FY2024, which is 9217.12% up from last year.
  • According to the latest figures from Q3 2025, Innoviva's Cash from Financing Activities is $10.8 million, which was up 17729.93% from $1.2 million recorded in Q2 2025.
  • Innoviva's Cash from Financing Activities' 5-year high stood at $60.3 million during Q1 2022, with a 5-year trough of -$440.4 million in Q3 2021.
  • Its 5-year average for Cash from Financing Activities is -$79.4 million, with a median of -$9.7 million in 2022.
  • As far as peak fluctuations go, Innoviva's Cash from Financing Activities tumbled by 367015833.33% in 2021, and later soared by 38311.12% in 2022.
  • Quarter analysis of 5 years shows Innoviva's Cash from Financing Activities stood at -$440.4 million in 2021, then surged by 89.65% to -$45.6 million in 2022, then crashed by 245.1% to -$157.2 million in 2023, then surged by 91.08% to -$14.0 million in 2024, then soared by 177.3% to $10.8 million in 2025.
  • Its Cash from Financing Activities was $10.8 million in Q3 2025, compared to $1.2 million in Q2 2025 and $183000.0 in Q1 2025.